Business Wire

SYNAPS Dx Completes $10 Million Series A Investment, Accelerates Commercialization of DISCERN: First Minimally Invasive Test for Accurate Diagnosis of Alzheimer’s Disease

ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of diagnostics for neurodegenerative disorders and conditions, ...
Healio

SYNAPS Dx opens lab to support launch of minimally invasive AD diagnostic test

Please provide your email address to receive an email when new articles are posted on . SYNAPS Dx has announced the opening of a new laboratory to support the launch of DISCERN, a minimally invasive ...
Business Wire

SYNAPS Dx Honors Researchers, Providers, Patients and Families During World Alzheimer’s Month

ROCKVILLE, Md.--(BUSINESS WIRE)--SYNAPS Dx (SDx), a privately held company focused on the research, development and commercialization of a diagnostic test for Alzheimer’s disease (AD), recognizes ...